# Topical Imiquimod Treatment of Oral Dysplasia

> **NCT07210775** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of Southern California** · enrollment: 20 (estimated)

## Conditions studied

- Oral Dysplasia
- Leukoplakia Oral
- Leukoplakia

## Interventions

- **DRUG:** Imiquimod (topical use)

## Key facts

- **NCT ID:** NCT07210775
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2027-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07210775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07210775, "Topical Imiquimod Treatment of Oral Dysplasia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07210775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*